Trelstar LA

Generic name:triptorelin (intramuscular route) [ trip-toe-REL-in ]
Drug classes:Gonadotropin releasing hormones, Hormones / antineoplastics

Medically reviewed by Drugs.com. Last updated on Mar 1, 2022.

Commonly used brand name(s)

In the U.S.

• Trelstar
• Trelstar Depot
• Trelstar LA
• Triptodur

Available Dosage Forms:

• Powder for Suspension
• Powder for Suspension, 6 Month

Therapeutic Class: Antineoplastic Agent

Pharmacologic Class: Luteinizing Hormone Releasing Hormone Agonist

Uses for Trelstar LA

Triptorelin is used to treat advanced prostate cancer in men. It is a hormone that is similar to the one normally released from the hypothalamus gland in the brain. When given on a regular basis to men, triptorelin decreases testosterone levels which helps treat prostate cancer.

Triptorelin is also used to treat central precocious puberty (CPP), a condition which causes early puberty in boys (before 9 years of age) and girls (before 8 years of age).

This medicine is to be given only by or under the supervision of a doctor.

Before using Trelstar LA

In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For this medicine, the following should be considered:

Allergies

Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.

Pediatric

Appropriate studies have not been performed on the relationship of age to the effects of triptorelin injection to treat advanced prostrate cancer in the pediatric population. Safety and efficacy have not been established.

Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of triptorelin injection to treat central precocious puberty in children 2 years of age and older. Safety and efficacy have not been established in children younger than 2 years of age.

Geriatric

Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of triptorelin injection to treat advanced prostrate cancer in the elderly.

No information is available on the relationship of age to the effects of Triptodur® in the elderly.

Breastfeeding

There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.

Interactions with medicines

Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are ...